Pathology characteristics that optimize outcome prediction of a breast screening trial
2000

Pathology Characteristics and Breast Cancer Screening Outcomes

Sample size: 1029 publication Evidence: high

Author Information

Author(s): Anderson T J, Alexander F E, Lamb J, Smith A, Forrest A P M

Primary Institution: University of Edinburgh

Hypothesis

Pathology characteristics can predict outcomes in breast cancer screening trials.

Conclusion

Pathology characteristics significantly predict survival outcomes in breast cancer patients, particularly in operable cases.

Supporting Evidence

  • 55.7% of the cancers were in the screening arm, which had more operable cases.
  • The reduction in inoperable breast cancers was a notable effect of the trial.
  • In operable invasive cases, various pathology features showed significant association with survival.

Takeaway

Doctors can use certain features of breast cancer to better predict how well patients will do after treatment.

Methodology

The study analyzed 1029 cancers from the Edinburgh Randomized Trial of breast screening over 14 years.

Limitations

The weighting factors for pathology indicators in the Nottingham Prognostic Index may not be optimal for the trial population.

Participant Demographics

The majority of participants were women invited to mammographic screening in the UK.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1054/bjoc.2000.1286

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication